€58.10
1.02%
Xetra, Dec 06, 05:35 pm CET
ISIN
DE0005313704
Symbol
AFX
Index
Sector

Carl Zeiss Meditec Stock price

€58.10
+1.20 2.11% 1M
-27.35 32.01% 6M
-40.74 41.22% YTD
-28.08 32.58% 1Y
-103.90 64.14% 3Y
-45.00 43.65% 5Y
+37.60 183.41% 10Y
Xetra, Closing price Fri, Dec 06 2024
-0.60 1.02%
ISIN
DE0005313704
Symbol
AFX
Index
Sector

Key metrics

Market capitalization €5.20b
Enterprise Value €5.46b
P/E (TTM) P/E ratio 19.89
EV/FCF (TTM) EV/FCF 30.05
EV/Sales (TTM) EV/Sales 2.65
P/S ratio (TTM) P/S ratio 2.52
P/B ratio (TTM) P/B ratio 2.48
Dividend yield 1.89%
Last dividend (FY23) €1.10
Revenue growth (TTM) Revenue growth 1.98%
Revenue (TTM) Revenue €2.06b
EBIT (operating result TTM) EBIT €298.58m
Free Cash Flow (TTM) Free Cash Flow €181.57m
EPS (TTM) EPS €2.92
P/E forward 32.61
P/S forward 2.51
EV/Sales forward 2.64
Show more

Is Carl Zeiss Meditec a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,879 stocks worldwide.

Carl Zeiss Meditec Stock Analysis

Unlock Scores for Free

Analyst Opinions

16 Analysts have issued a Carl Zeiss Meditec forecast:

4x Buy
25%
9x Hold
56%
3x Sell
19%

Analyst Opinions

16 Analysts have issued a Carl Zeiss Meditec forecast:

Buy
25%
Hold
56%
Sell
19%

Financial data from Carl Zeiss Meditec

Income Statement P&L | Balance Sheet | Cash Flow


TTM Annually
Mar '24
+/-
%
2,062 2,062
2% 2%
100%
- Direct Costs 901 901
6% 6%
44%
1,161 1,161
1% 1%
56%
- Selling and Administrative Expenses 429 429
6% 6%
21%
- Research and Development Expense 358 358
10% 10%
17%
374 374
16% 16%
18%
- Depreciation and Amortization 75 75
2% 2%
4%
EBIT (Operating Income) EBIT 299 299
19% 19%
14%
Net Profit 261 261
6% 6%
13%

In millions EUR.

Don't miss a Thing! We will send you all news about Carl Zeiss Meditec directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Carl Zeiss Meditec Stock News

AD HOC NEWS
18 days ago
Der Kursabschwung von Carl Zeiss Meditec DE0005313704 ist am Donnerstag mit einem erneuten Sechsjahrestief weiter gegangen.
AD HOC NEWS
about one month ago
Die kanadische Bank RBC hat Carl Zeiss Meditec DE0005313704 von "Outperform" auf "Sector Perform" abgestuft und das Kursziel von 85 auf 70 Euro gesenkt.
AD HOC NEWS
about one month ago
Die Schweizer Großbank UBS hat das Kursziel für Carl Zeiss Meditec DE0005313704 von 71 auf 65 Euro gesenkt, aber die Einstufung auf "Neutral" belassen.
More Carl Zeiss Meditec News

Company Profile

Carl Zeiss Meditec AG engages in the development, manufacture, and marketing of medical devices. It operates through the Ophthalmic Devices and Microsurgery business segments. The Ophthalmic Devices segment includes intraocular lenses, surgical visualization solutions, and medical laser and diagnostic systems. The Microsurgery segment offers surgical microscopes and visualization solutions for neuro, ear, nose, and throat surgery, as well as the activities in the field of intraoperative radiotherapy. The company was founded on October 4, 1995 and is headquartered in Jena, Germany.

Head office Germany
CEO Markus Weber
Employees 4,823
Founded 1995
Website www.zeiss.de

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today